LEONARDI, FRANCESCO
LEONARDI, FRANCESCO
Dipartimento di Medicina e Chirurgia
Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals
2021-01-01 Bui, Simona; Pelosi, Annalisa; Mazzaschi, Giulia; Tommasi, Chiara; Rapacchi, Elena; Camisa, Roberta; Binovi, Cinzia; Leonardi, Francesco
Circulating TGF-Beta and PD-L1 in Pancreatic Cancer
2022-01-01 Garajova, Ingrid; Cavazzoni, Andrea; Verze, Michela; Minari, Roberta; Pedrazzi, Giuseppe; Balsano, Rita; Digiacomo, Graziana; Leonardi, Francesco
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study (Drugs in R&D, (2017), 17, 4, (585-596), 10.1007/s40268-017-0209-5)
2018-01-01 Buti, S.; Donini, M.; Bersanelli, M.; Gattara, A.; Leonardi, F.; Passalacqua, R.
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab
2019-01-01 Bersanelli, M.; Gnetti, L.; Vaglio, A.; Sverzellati, N.; Campanini, N.; Incerti, M.; Galetti, M.; Varotti, E.; Corrado, M.; Parziale, R.; Bottarelli, L.; Azzoni, C.; Silini, E. M.; Leonardi, F.; Buti, S.
Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
2017-01-01 Buti, S.; Donini, M.; Bersanelli, M.; Gattara, A.; Leonardi, F.; Passalacqua, R.
It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer
2022-01-01 Garajová, Ingrid; Cavazzoni, Andrea; Verze, Michela; Minari, Roberta; Pedrazzi, Giuseppe; Balsano, Rita; Gelsomino, Fabio; DALLA VALLE, Raffaele; Digiacomo, Graziana; Giovannetti, Elisa; Leonardi, Francesco
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review
2016-01-01 Pellegrino, B.; Sikokis, A.; Bersanelli, M.; Leonetti, A.; Leonardi, F.; Di Meglio, G.; Buti, S.
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity
2023-01-01 Bersanelli, Melissa; Gnetti, Letizia; Pilato, Francesco Paolo; Varotti, Elena; Quaini, Federico; Campanini, Nicoletta; Rapacchi, Elena; Camisa, Roberta; Carbognani, Paolo; Silini, Enrico Maria; Rusca, Michele; Leonardi, Francesco; Maestroni, Umberto; Rizzo, Mimma; Brunelli, Matteo; Buti, Sebastiano; Ampollini, Luca
Should patients on levothyroxine therapy be screened for pancreatic cancer?
2022-01-01 Garajova, Ingrid; Balsano, Rita; Coriano', Matilde; Gelsomino, Fabio; Tovoli, Francesco; De Lorenzo, Stefania; Del Rio, Paolo; Dalla Valle, Raffaele; Ravaioli, Matteo; Leonardi, Francesco
Stage III and metastatic Lymph Node Ratio are the only independent prognostic factors in colorectal signet-ring cell carcinoma patients
2020-01-01 Annicchiarico, Alfredo; Morini, Andrea; Romboli, Andrea; Riccò, Matteo; Leonardi, Francesco; Crafa, Pellegrino; Virgilio, Edoardo; Dell'Abate, Paolo; Costi, Renato
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals | 1-gen-2021 | Bui, Simona; Pelosi, Annalisa; Mazzaschi, Giulia; Tommasi, Chiara; Rapacchi, Elena; Camisa, Roberta; Binovi, Cinzia; Leonardi, Francesco | |
| Circulating TGF-Beta and PD-L1 in Pancreatic Cancer | 1-gen-2022 | Garajova, Ingrid; Cavazzoni, Andrea; Verze, Michela; Minari, Roberta; Pedrazzi, Giuseppe; Balsano, Rita; Digiacomo, Graziana; Leonardi, Francesco | |
| Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study (Drugs in R&D, (2017), 17, 4, (585-596), 10.1007/s40268-017-0209-5) | 1-gen-2018 | Buti, S.; Donini, M.; Bersanelli, M.; Gattara, A.; Leonardi, F.; Passalacqua, R. | |
| Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab | 1-gen-2019 | Bersanelli, M.; Gnetti, L.; Vaglio, A.; Sverzellati, N.; Campanini, N.; Incerti, M.; Galetti, M.; Varotti, E.; Corrado, M.; Parziale, R.; Bottarelli, L.; Azzoni, C.; Silini, E. M.; Leonardi, F.; Buti, S. | |
| Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study | 1-gen-2017 | Buti, S.; Donini, M.; Bersanelli, M.; Gattara, A.; Leonardi, F.; Passalacqua, R. | |
| It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer | 1-gen-2022 | Garajová, Ingrid; Cavazzoni, Andrea; Verze, Michela; Minari, Roberta; Pedrazzi, Giuseppe; Balsano, Rita; Gelsomino, Fabio; DALLA VALLE, Raffaele; Digiacomo, Graziana; Giovannetti, Elisa; Leonardi, Francesco | |
| Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review | 1-gen-2016 | Pellegrino, B.; Sikokis, A.; Bersanelli, M.; Leonetti, A.; Leonardi, F.; Di Meglio, G.; Buti, S. | |
| Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity | 1-gen-2023 | Bersanelli, Melissa; Gnetti, Letizia; Pilato, Francesco Paolo; Varotti, Elena; Quaini, Federico; Campanini, Nicoletta; Rapacchi, Elena; Camisa, Roberta; Carbognani, Paolo; Silini, Enrico Maria; Rusca, Michele; Leonardi, Francesco; Maestroni, Umberto; Rizzo, Mimma; Brunelli, Matteo; Buti, Sebastiano; Ampollini, Luca | |
| Should patients on levothyroxine therapy be screened for pancreatic cancer? | 1-gen-2022 | Garajova, Ingrid; Balsano, Rita; Coriano', Matilde; Gelsomino, Fabio; Tovoli, Francesco; De Lorenzo, Stefania; Del Rio, Paolo; Dalla Valle, Raffaele; Ravaioli, Matteo; Leonardi, Francesco | |
| Stage III and metastatic Lymph Node Ratio are the only independent prognostic factors in colorectal signet-ring cell carcinoma patients | 1-gen-2020 | Annicchiarico, Alfredo; Morini, Andrea; Romboli, Andrea; Riccò, Matteo; Leonardi, Francesco; Crafa, Pellegrino; Virgilio, Edoardo; Dell'Abate, Paolo; Costi, Renato |